Susanne Schaffert - Jul 29, 2022 Form 4 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role
Director
Signature
/s/ Maiken Keson-Brookes, as Attorney-in-Fact
Stock symbol
RUBY
Transactions as of
Jul 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/1/2022, 05:38 PM
Previous filing
Jul 19, 2022
Next filing
Oct 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RUBY Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jul 29, 2022 Common Stock 50K $0.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in equal quarterly installments over the twelve quarters following the grant date.